Women's health technology is entering an exciting new era, and the latest innovation from health tech startup Vivoo is making waves for all the right reasons. Unveiled at CES 2026, the FlowPad represents a brilliant fusion of everyday necessity and cutting-edge health monitoring, turning an ordinary menstrual pad into a powerful tool for understanding your body.

The FlowPad measures follicle-stimulating hormone (FSH) levels using menstrual blood, offering valuable insights into fertility, hormonal patterns, and overall reproductive health. What makes this innovation truly special is its simplicity and accessibility. Women can simply use the pad as they normally would, then check their results either directly on the pad or through the Vivoo app for more detailed insights.

"The main goal here is to make one hygienic pad less than $5, so a period won't cost you more than $30," explains Vivoo CEO and cofounder Miray Tayfun. This commitment to affordability is refreshing in a market where health monitoring devices often come with hefty price tags. The team at Vivoo clearly understands that menstrual products should be accessible to everyone, not a luxury item.

The technology behind the FlowPad is impressively sophisticated yet elegantly simple. The pad features two specialized layers: a capillary capture layer that draws in blood and filters particles, and a biomarker reaction layer containing stabilized reagents that detect FSH levels. The results appear in a windowed area on the back of the pad, similar to a pregnancy test, making them easy to read and understand.

For women seeking to understand their fertility, manage conditions like polycystic ovary syndrome (PCOS), or navigate the transition into perimenopause, this innovation offers an empowering solution. Instead of expensive lab visits or complicated testing procedures, women can gain meaningful health insights during their regular daily routine. The ideal users are those in their 30s to mid-40s who want to take a proactive approach to their reproductive health.

Tayfun recommends wearing the FlowPad on the second or third day of your cycle, either continuously for a few months or intermittently depending on your health goals. The flexibility of use means women can customize their tracking experience to match their specific needs and circumstances.

What's particularly heartening about this innovation is how it addresses a real gap in women's healthcare. For too long, understanding hormone levels has required expensive tests and doctor's visits. The FlowPad democratizes this information, putting it literally in the hands of the people who need it most.

Vivoo plans to initially roll out the FlowPad to researchers, medical partners, and existing users before a broader launch. The company is exploring various pricing options, including subscriptions and pack configurations, to ensure maximum accessibility.

This breakthrough represents more than just technological innovation—it's a step toward a future where women have better tools to understand and care for their bodies. By transforming an everyday necessity into a health monitoring device, Vivoo is helping women take charge of their reproductive health in an affordable, convenient, and empowering way.